» Articles » PMID: 758419

Reduced Serum 25-hydroxyvitamin D Concentration and Disordered Mineral Metabolism in Patients with Cystic Fibrosis

Overview
Journal J Pediatr
Specialty Pediatrics
Date 1979 Jan 1
PMID 758419
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D and mineral metabolism were studied in 21 adolescents and young adults with cystic fibrosis and the results were compared to those in 21 matched controls. All CF patients had been maintained on standard multivitamin supplements in combination with pancreatic enzyme replacement. Despite this supplementation, relative to control subjects the CF patients had a 36% reduction in serum 25-hydroxyvitamin D concentration, a slight but significant reduction in serum calcium concentration, evidence of calcium malabsorption with secondary hyperparathyroidism, and a 14% decrease in bone mass measured by the photon absorption technique. Currently accepted modes of pancreatic enzyme replacement and vitamin D supplementation are often inadequate to maintain normal mineral homeostasis in CF patients; additional measurements may be required to reduce the risk of clinically significant osteopenia concomitant with prolonged survival in CF.

Citing Articles

Testosterone concentrations and associated predictors in men with cystic fibrosis: A retrospective, single-center study.

Jathal I, Wang Y, Binongo J, Cobb C, Hunt W, Khan F Am J Med Sci. 2024; 368(6):637-647.

PMID: 38997066 PMC: 11563879. DOI: 10.1016/j.amjms.2024.07.013.


Vitamin D deficiency in patients with cystic fibrosis: a systematic review and meta-analysis.

Farahbakhsh N, Fatahi S, Shirvani A, Motaharifard M, Mohkam M, Tabatabaii S J Health Popul Nutr. 2024; 43(1):11.

PMID: 38233891 PMC: 10795301. DOI: 10.1186/s41043-024-00499-2.


A comparative absorption study of sucrosomial orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency-Results from....

Bano A, Abrar S, Brilli E, Tarantino G, Bugti A, Fabbrini M Front Nutr. 2023; 10:1221685.

PMID: 37662595 PMC: 10469777. DOI: 10.3389/fnut.2023.1221685.


Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.

Fonseca O, Gomes M, Amorim M, Gomes A Biomolecules. 2023; 13(3).

PMID: 36979360 PMC: 10046889. DOI: 10.3390/biom13030425.


Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management.

Patel D, Shan A, Mathews S, Sathe M Nutrients. 2022; 14(5).

PMID: 35268004 PMC: 8912424. DOI: 10.3390/nu14051028.